Skip to content
Third-party HPLC + mass spec on every lot
Drag to rotate · 360°

Melanotan II

Cyclic α-MSH analogue, non-selective melanocortin agonist

A cyclic lactam-bridged alpha-MSH analogue with broad melanocortin receptor activity. The cyclisation is what makes it stable — and what makes it hard to verify.

Current lot verified

CP-MELANORR-2606A · tested Jun 18, 2026

99.75 %

HPLC purity

Read this lot’s certificate

About Melanotan II

Melanotan II is a cyclic heptapeptide analogue of alpha-melanocyte stimulating hormone, closed by a lactam bridge between aspartate and lysine side chains. The cyclisation constrains the molecule into the bioactive conformation and confers resistance to proteolysis that the linear parent lacks. It is a non-selective agonist across MC1R, MC3R, MC4R and MC5R, and that lack of selectivity is precisely why it is useful for mapping which receptor subtype drives which observed effect — usually in combination with selective antagonists.

The quality-critical issue is whether the lactam bridge actually closed. Cyclisation is the last and least reliable step in the synthesis, and linear uncyclised material differs from the cyclic product by only 18 daltons — one water molecule. A mass spectrometer set to normal tolerances on a 1024 Da peptide can miss that. We resolve cyclic from linear chromatographically, and the certificate reports linear content as its own line.

Published research areas

  • Melanocortin receptor subtype pharmacology
  • Melanogenesis in melanocyte culture
  • Cyclic peptide conformational studies
  • Receptor selectivity mapping

Specifications

CAS number
121062-08-6
Molecular formula
C50H69N15O9
Molecular weight
1024.18 g/mol
Release specification
≥ 99.0 % by HPLC
Appearance
White lyophilised powder
Solubility
Soluble in water and bacteriostatic water
Storage
-20 °C lyophilised, protected from light
Format
lyophilized vial

Sequence

Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2

Handling and reconstitution

Check the linear-content line on the certificate. Uncyclised material is the single most common defect in this compound across the market.

Storage: -20 °C lyophilised, protected from light

Full reconstitution and storage reference

Lot history

Every released lot of this compound, oldest kept on file. Average across 2 lots: 99.56 %.

LotStrengthPurityTestedLaboratory
CP-MELANORR-2606A10 mg99.75 %Jun 18, 2026Janoshik AnalyticalCertificate →
CP-MELANORR-2605B20 mg99.37 %May 9, 2026Aurum BioanalyticsCertificate →

Others in Dermal & Cosmetic

Dermal & Cosmetic

SNAP-8

Acetyl octapeptide-3

≥ 98.0 % HPLC·COA on file

From

$65

Dermal & Cosmetic

PT-141

Bremelanotide, MC4R-preferring agonist

≥ 99.0 % HPLC·COA on file

From

$72